Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Spike Protein Equipment Supplied In Europe
24 equipment items found
Manufactured by:ExcellGene SA based inMonthey, SWITZERLAND
The Alpha variant, also known as B.1.1.7., was emerging as a VOCs after a mutation in the spike protein D614G, was recognized as possibly affecting the infectivity in people in an enhanced way. The Alpha variant carried this mutation and others, for example, N501Y, and was considered 40-80% more transmissible than the original “Wuhan” ...
Manufactured by:ExcellGene SA based inMonthey, SWITZERLAND
We've created a stable, clonally derived, recombinant, suspension grown CHO cell line that produces a secreted, stabilized version of the trimeric spike protein of ...
Manufactured by:ExcellGene SA based inMonthey, SWITZERLAND
The beta variant — initially found in South Africa — showed additional mutations in the spike protein, the most important ones as K417N, E484K and N501Y (the last one was found already in the Beta variant). Also, the early mentioned D614G mutation remained in this variant. ...
Manufactured by:Immunodiagnostic Systems Holdings PLC based inBoldon Colliery, UNITED KINGDOM
The Spike Protein Inhibition Assay (SPIA) is a competitive immunoenzymatic colorimetric method used for research purposes only to detect neutralising antibodies against SARS-CoV-2 in human ...
Manufactured by:ExcellGene SA based inMonthey, SWITZERLAND
It contains again the 614G mutations and others, notably a proline to arginine substitution that may facilitate the cleavage of the S precursor into the S1/S2 conversion, which results in the fusion of the spike protein with the cell membrane receptor ...
Manufactured by:ExcellGene SA based inMonthey, SWITZERLAND
The SARS-CoV-2 Omicron variant became known to the general public recently (end of November 2021) and is characterized by many mutations in the Spike protein and other regions of the virus genome. It seems to spread even more rapidly than the Delta variant, and questions about the protection against this variant by presently used vaccines have been raised. This ...
Manufactured by:Prima Lab SA based inBalerna, SWITZERLAND
COVID-19 Neutralising IgG Serological Test is a rapid device which verifies the presence of COVID-19 neutralising IgG antibodies in human blood samples produced after the end of the vaccination cycle. ...
Manufactured by:ExcellGene SA based inMonthey, SWITZERLAND
In addition to stabilized trimeric spike proteins, we also offer the RBD domain produced in the same CHO cell system. The RBD protein is easier to produce and to purify and is therefore an ideal alternative for applications where costs are the driving factor. Please contact us to learn about our pricing per gram or mg of RBD ...
Manufactured by:Virometix AG based inSchlieren, SWITZERLAND
Our epitope-focused SVLP-based vaccine aims to target specific regions of the Receptor Binding Domain (RBD) of the Spike protein. Proof-of-concept studies are currently ongoing using SARS-CoV-2, where five Synthetic Antigen Mimetics (SAM) were rapidly designed and synthesized for an optimal neutralization ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
In 2012, within weeks of obtaining the sequence of the circulating MERS strain, we successfully produced a vaccine candidate. Our MERS candidate was based on the major surface spike protein, which we had previously identified as the antigen of choice in our work with our SARS vaccine candidate. In 2014, in collaboration with the University of Maryland School of ...
Manufactured by:Yourgene Health based inManchester, UNITED KINGDOM
COVID-19 (also referred to as Coronavirus), is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Coronaviruses are enveloped RNA viruses. They are names as such due to the spike proteins projecting from their surface. SARS-CoV-2 is one of 7 total coronaviruses that commonly infect humans and is one of the 5 beta ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
In 2012, within weeks of obtaining the sequence of the circulating MERS strain, we successfully produced a vaccine candidate. Our MERS candidate was based on the major surface spike protein, which we had previously identified as the antigen of choice in our work with our SARS vaccine candidate. In 2014, in collaboration with the University of Maryland School of ...
Manufactured by:Tonix Pharmaceuticals Holding Corp. based inChatham, NEW JERSEY (USA)
TNX-1850 is the planned new version of the TNX-1800 vaccine that encodes spike protein from SARS-CoV-2 BA.2 ...
Manufactured by:Institut Virion\Serion GmbH based inWurzburg, GERMANY
Sometimes we are confronted with extreme situations that require extraordinary solutions. Our new product line supports in such situations and offers qualitative and quantitative immunoassays for the detection of human antibodies directed against specific antigens of bacteria, viruses, fungi and parasites in serum or plasma. SERION ELISA agile is optimized for a higher test throughout while ...
Manufactured by:BAG Diagnostics GmbH based inLich, GERMANY
Fast detection of variants? With our clever real-time ViroQ® SC2 Variant 1 / Variant 2 and Variant 3 kits you can react quickly to variants of the SARS-CoV-2 virus of origin. In contrast to gene-seqeuncing, which takes about 30 hours, the real-time PCR tests deliver results on the most important mutants in only 60 ...
by:Attomarker Ltd based inExeter, UNITED KINGDOM
The following single-chip panels are available for the Liscar 6 platform. Additional panels will be highlighted here as they come on stream so please check back regularly or get in touch so that we can notify you when new panels are released. ...
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
IVX-411 targets SARS-CoV-2, the coronavirus that causes COVID-19. Developed using cutting-edge structure-based design techniques at the Institute for Protein Design at the UW School of Medicine, IVX-411, our lead vaccine candidate for COVID-19, is a self-assembling protein nanoparticle that displays 60 copies of the SARS-CoV-2 spike (S) ...
by:Diasorin based inSALUGGIA, ITALY
DiaSorin strives to improve health-care around the globe through the development of innovative diagnostic solutions that can lead to better patient outcomes and provide economic benefits to the healthcare system. Thanks to its team of dedicated scientists DiaSorin has been able to promptly deliver diagnostic solutions to manage the COVID-19 pandemic ...
Manufactured by:Biopanda Reagents Ltd based inBelfast, UNITED KINGDOM
The Biopanda COVID-19 RBD IgG Rapid Test Kit is a highly sensitive, qualitative lateral flow immunochromatographic assay for the detection of specific anti-Receptor Binding Domain (RBD) IgG antibodies to SARS-CoV-2 in human whole blood, serum or plasma samples. This test is intended for the detection of antibodies generated by vaccinations. This test kit is CE-marked for healthcare professional ...
Manufactured by:OSE Immunotherapeutics based inNantes, FRANCE
CoVepiT, a multi-target and multi-variant vaccine candidate against COVID-19. CoVepiT is a next-generation multi-target, multi-variant vaccine against SARS-CoV-2 in clinical Phase 1. The vaccine candidate was designed using optimized epitopes selected after screening more than 67,000 global SARS-CoV-2 genomes, as well as those of previous human-infective CoVs, SARS and MERS, to identify vaccine ...